News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
恒瑞醫藥(01276.HK)向上海瑞宏迪增資2.85億人民幣
恒瑞醫藥(01276.HK)公布，與恒瑞集團、盛迪生物醫藥基金及深圳迎泰向上海瑞宏迪合共增資7.5億人民幣，其中，公司出資2.85億人民幣，完成後，上海瑞宏迪註冊資本將增加至2.3億人民幣，公司持股維持38%。(de/d)~阿思達克財經新聞網址: www.aastocks.com
Reset
Send
The window will close in 5 seconds
恒瑞醫藥(01276.HK)向上海瑞宏迪增資2.85億人民幣
Close
Recommend
2
Positive
3
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

恒瑞醫藥(01276.HK)  -0.250 (-0.374%)    Short selling $30.73M; Ratio 25.836%   公布，與恒瑞集團、盛迪生物醫藥基金及深圳迎泰向上海瑞宏迪合共增資7.5億人民幣，其中，公司出資2.85億人民幣，完成後，上海瑞宏迪註冊資本將增加至2.3億人民幣，公司持股維持38%。(de/d)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

AASTOCKS新聞

Switch to Auto-Translated Version
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.